Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
AC073111.3		ENSG00000284691	"Novel zinc finger protein"		7	150400702-150412470	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 22.6;dendritic cells: 26.1"					"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 3.7;MAIT T-cell: 2.7;memory B-cell: 4.6;memory CD4 T-cell: 4.9;memory CD8 T-cell: 3.3;naive B-cell: 5.8;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.7;plasmacytoid DC: 8.9;T-reg: 3.7"	"Group enriched"	"Detected in many"	7	"B-cells: 5.8;dendritic cells: 8.9;T-cells: 5.4"	"Cancer enhanced"	"Detected in many"		"Myeloma: 17.5"		"Low region specificity"	"Detected in all"													NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"		"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"																				
AC093525.1		ENSG00000259784	"Novel protein"		16	2513965-2527955	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 1.6;intestine: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"																		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: Non-specific - Transcription"	"Cluster 62: B-cells - B-cell activation"																				
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 226.9;Gastric mucus-secreting cells: 133.0;Ionocytes: 77.4;Microglial cells: 227.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"
AFF3	"LAF4, MLLT2-like"	ENSG00000144218	"AF4/FMR2 family member 3"	P51826	2	99545419-100192428	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Dwarfism, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 222.7;dendritic cells: 122.9;Excitatory neurons: 484.1;Inhibitory neurons: 293.5;Oligodendrocyte precursor cells: 202.6;Prostatic glandular cells: 143.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 11.4;prostate cancer: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 31.0;naive B-cell: 44.2;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	17	"B-cells: 44.2;dendritic cells: 23.9"	"Cancer enhanced"	"Detected in many"		"lymphoma: 22.4"	"Kidney - Fibroblasts, Prostate - Prostate glandular cells, Skeletal muscle - Fibroblasts"	"Low region specificity"	"Detected in all"							"HPA044512, HPA053379"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA044512: AB_10795984, HPA053379: AB_2682133"	"unprognostic (1.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.98e-5)"	"unprognostic (1.11e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.95e-3)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (6.40e-3)"	"unprognostic (6.79e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.87e-3)"
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.5;lymphoid tissue: 50.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 70.9;Early spermatids: 22.0;Late spermatids: 35.3;Plasma cells: 29.2;Schwann cells: 15.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"memory B-cell: 143.8;naive B-cell: 63.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 143.8"	"Cancer enhanced"	"Detected in many"		"lymphoma: 44.5;Myeloma: 24.2"	"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: AB_2676925"	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"
AL645941.2		ENSG00000248993	"Novel  protein"		6	32937364-32953122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.7;Erythroid cells: 1.9;Macrophages: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA012298	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"		"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"	
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 150.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959441-145964575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;skeletal muscle: 6.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.6;Bipolar cells: 10.5;Excitatory neurons: 6.0;Inhibitory neurons: 5.7;Microglial cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 47: Non-specific - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 183.4;Microglial cells: 380.4;NK-cells: 145.7;Oligodendrocyte precursor cells: 167.5;Oligodendrocytes: 188.3;T-cells: 135.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 31.6"	"Adipose visceral - T-cells, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Mitochondria	"Nuclear speckles"	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.5;granulocytes: 36.3;Hofbauer cells: 42.7;Microglial cells: 85.7;NK-cells: 71.4;T-cells: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 657.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Leukemia: 25.0;lymphoma: 39.2;Myeloma: 13.6"	"Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF, p114RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7348937-7472485	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042689, HPA049151, HPA071867"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 53: Non-specific - mRNA processing"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA042689: AB_10794385, HPA049151: AB_2680654, HPA071867: AB_2686466"	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.5;B-cells: 69.5;Langerhans cells: 72.8;monocytes: 61.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 101.5;salivary gland: 185.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.8;dendritic cells: 72.1;Distal enterocytes: 108.8;Enteroendocrine cells: 74.9;Gastric mucus-secreting cells: 119.2;Intestinal goblet cells: 130.5;Plasma cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 129.6;lymphoma: 112.9"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - T-cells, Liver - T-cells, Skin - Eccrine sweat gland cells, Stomach - Gastric mucous cells"	"Region enriched"	"Detected in all"	15	"cerebellum: 67.2"	"Low region specificity"	"Detected in all"			"HPA007180, CAB010882"	Approved					NA	NA		5400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favorable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favorable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"		"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.2;lymphoid tissue: 96.4"	"Cell type enriched"	"Detected in many"	10	"B-cells: 461.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"memory B-cell: 310.4;naive B-cell: 253.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 310.4"	"Group enriched"	"Detected in many"	4	"Leukemia: 9.9;lymphoma: 16.6;Myeloma: 10.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		19000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"
BCAS4	"CNOL, FLJ20495"	ENSG00000124243	"Breast carcinoma amplified sequence 4"	Q8TDM0	20	50794894-50882676	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 81.1;Distal tubular cells: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 73.9;naive B-cell: 76.1"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"lymphoma: 83.3"	"Testis - Sertoli cells"					"Low region specificity"	"Detected in all"			HPA038812	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Intermediate filaments, Cytosol"		"HPA038812: AB_10795141"	"unprognostic (3.48e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.30e-2)"
BEND5	"C1orf165, FLJ11588"	ENSG00000162373	"BEN domain containing 5"	Q7L4P6	1	48727519-48776969	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Club cells: 28.8;Cone photoreceptor cells: 31.0;Distal tubular cells: 31.1;Proximal tubular cells: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 6.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 8.0"	"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 3.9"	"Liver - Hepatic stellate cells, Prostate - Fibroblasts"	"Low region specificity"	"Detected in many"							"HPA054347, HPA058007"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nuclear speckles"	Cytosol	"HPA054347: AB_2682456, HPA058007: AB_2683577"	"prognostic favorable (2.50e-5)"	"unprognostic (1.36e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.42e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.68e-2)"	"prognostic favorable (8.30e-6)"
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564599	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 39.1;lymphoid tissue: 46.7"	"Cell type enriched"	"Detected in some"	14	"B-cells: 152.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 183.4;naive B-cell: 131.5"	"Lineage enriched"	"Detected in many"	5	"B-cells: 183.4"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 61.3"	"Breast - Plasma cells, Lung - B-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB005093, HPA069571"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96189171-96271587	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 99.3;dendritic cells: 119.9;Microglial cells: 153.2;Plasma cells: 80.3;Proximal enterocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5"	"Group enriched"	"Detected in many"	101	"B-cells: 161.2;dendritic cells: 231.5"	"Group enriched"	"Detected in many"	5	"Leukemia: 31.7;lymphoma: 69.2;Myeloma: 19.0"	"Colon - T-cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	Vesicles	"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946"	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favorable (2.67e-6)"
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463966-112499472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 64.2;dendritic cells: 18.5;Plasma cells: 21.9;Schwann cells: 20.8;T-cells: 9.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 65.0;naive B-cell: 96.5;plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	4	"B-cells: 96.5;dendritic cells: 24.9"	"Group enriched"	"Detected in some"	5	"lymphoma: 3.4;Myeloma: 12.4"	"Breast - Plasma cells"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.0;dendritic cells: 36.4;Microglial cells: 48.3;NK-cells: 52.7;T-cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cancer enhanced"	"Detected in many"		"lymphoma: 69.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"
CCDC106	HSU79303	ENSG00000173581	"Coiled-coil domain containing 106"	Q9BWC9	19	55641062-55653161	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 9.6"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041925, HPA043219"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Rabdoid cancer - Embryonic development"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA041925: AB_2677750, HPA043219: AB_2678368"	"unprognostic (5.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.88e-2)"	"unprognostic (8.74e-2)"	"prognostic favorable (2.23e-6)"	"unprognostic (2.28e-1)"	"prognostic favorable (7.54e-11)"	"unprognostic (5.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.26e-1)"	"unprognostic (8.69e-2)"
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 33.0;lymphoid tissue: 75.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 130.2;Early spermatids: 49.1;Plasma cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	80	"memory B-cell: 138.2;naive B-cell: 172.1"	"Lineage enriched"	"Detected in many"	89	"B-cells: 172.1"	"Group enriched"	"Detected in some"	13	"Leukemia: 36.7;lymphoma: 69.1"	"Liver - T-cells, Lung - B-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 141.3;lymphoid tissue: 230.2;ovary: 132.8"	"Group enriched"	"Detected in many"	7	"B-cells: 157.6;granulocytes: 47.4;Granulosa cells: 51.9;Oligodendrocytes: 86.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.6;naive B-cell: 120.3"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.3"	"Cancer enriched"	"Detected in many"	4	"lymphoma: 197.3"	"Colon - Mast cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002418, HPA024353, HPA066523"	Enhanced					NA	NA		13000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1698.7;dendritic cells: 539.1;granulocytes: 459.9;Hofbauer cells: 485.4;Langerhans cells: 414.6;monocytes: 749.0;NK-cells: 383.4;T-cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 70.9;lymphoma: 194.7"	"Breast - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Group enriched"	"Detected in many"	5	"B-cells: 947.5;granulocytes: 1937.7;NK-cells: 517.3;T-cells: 1179.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Group enriched"	"Detected in some"	6	"Leukemia: 44.2;lymphoma: 26.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609979-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 65.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.0;dendritic cells: 17.4;Hofbauer cells: 18.3;Langerhans cells: 17.0;Macrophages: 17.9;monocytes: 18.5;NK-cells: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 232.9;naive B-cell: 413.5"	"Lineage enriched"	"Detected in all"	20	"B-cells: 413.5"	"Group enriched"	"Detected in some"	25	"Leukemia: 21.9;lymphoma: 36.3"	"Prostate - T-cells, Thyroid - T-cells"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.1"	"Low region specificity"	"Detected in single"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877279-41881372	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 152.3;lymphoid tissue: 545.2"	"Group enriched"	"Detected in many"	27	"B-cells: 1218.9;Plasma cells: 661.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"memory B-cell: 1273.8;naive B-cell: 1457.5"	"Lineage enriched"	"Detected in all"	40	"B-cells: 1457.5"	"Cancer enriched"	"Detected in many"	4	"lymphoma: 740.6"	"Breast - Plasma cells, Lung - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000019, HPA056444"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB000019: AB_2244527, HPA056444: "	"prognostic favorable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 266.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 497.2;monocytes: 88.7;Plasma cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1132.1;naive B-cell: 1505.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1505.8"	"Cancer enriched"	"Detected in many"	6	"lymphoma: 593.0"	"Prostate - Endothelial cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.9;dendritic cells: 50.2;Spermatogonia: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Mesothelial cells, Lung - Alveolar cells type 2, Prostate - Prostate basal glandular cells, Testis - Spermatogonia, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center,Cytosol"		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 63: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Nucleoli"	"Nucleoli fibrillar center, Cytosol"	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"
CLEC17A	FLJ45910	ENSG00000187912	"C-type lectin domain containing 17A"	Q6ZS10	19	14583084-14612035	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 6.6;lymphoid tissue: 18.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 21.7;Early spermatids: 4.3;Late spermatids: 11.5;Microglial cells: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"memory B-cell: 21.5;naive B-cell: 43.1"	"Lineage enriched"	"Detected in many"	14	"B-cells: 43.1"	"Cancer enriched"	"Detected in some"	8	"lymphoma: 13.9"	"Lung - B-cells, Prostate - T-cells, Testis - Late spermatids"					"Not detected"	"Not detected"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (4.71e-5)"	"unprognostic (1.34e-2)"	"unprognostic (9.64e-4)"	"unprognostic (5.02e-3)"	"unprognostic (3.90e-1)"	"unprognostic (9.00e-4)"	"unprognostic (3.18e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 9.9;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 95.2;dendritic cells: 66.3;granulocytes: 38.8;Hofbauer cells: 24.6;Langerhans cells: 82.8;Macrophages: 23.9;Plasma cells: 33.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 120.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 120.9"	"Group enriched"	"Detected in some"	261	"Leukemia: 38.3;lymphoma: 86.1;Myeloma: 29.4"						"Low region specificity"	"Detected in many"			HPA063928			Supported	"Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	4	"B-cells: 35.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Group enriched"	"Detected in some"	12	"Leukemia: 2.9;lymphoma: 5.6"	"Lung - B-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 206.8;Microglial cells: 342.1;Rod photoreceptor cells: 208.9;Syncytiotrophoblasts: 382.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 15.0;naive B-cell: 9.4;plasmacytoid DC: 8.1"	"Group enriched"	"Detected in many"	13	"B-cells: 15.0;dendritic cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 68: Kidney - Mixed function"	"Cluster 62: B-cells - B-cell activation"	"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 174.0"	"Cell type enriched"	"Detected in some"	4	"B-cells: 44.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.1;stomach cancer: 5.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.3"	"Group enriched"	"Detected in some"	7	"Leukemia: 8.3;lymphoma: 16.8;Myeloma: 9.1"		"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced					NA	NA		220000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favorable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883892-118897787	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"B-cell activation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 10.6;intestine: 10.2;lymphoid tissue: 28.9"	"Cell type enriched"	"Detected in some"	14	"B-cells: 84.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"memory B-cell: 67.7;naive B-cell: 92.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 92.4"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 19.8"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026149, HPA042432"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB026149: , HPA042432: AB_2677995"	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"
DNAAF2	"C14orf104, CILD10, FLJ10563, KTU, PF13"	ENSG00000165506	"Dynein axonemal assembly factor 2"	Q9NVR5	14	49625174-49635244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002894, HPA004113"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 46: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA002894: AB_1078316, HPA004113: AB_1078315"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.25e-2)"	"prognostic favorable (6.74e-7)"	"unprognostic (6.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.44e-2)"
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463306-3501473	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 7.7;Basal prostatic cells: 6.4;Cardiomyocytes: 11.8;Late spermatids: 9.2;Skeletal myocytes: 8.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9"	"Group enriched"	"Detected in many"	16	"B-cells: 3.4;NK-cells: 1.9"	"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 2: DU4475 - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 194.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177154-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.9;Plasma cells: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.4;naive B-cell: 8.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.4"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: AB_2682897, HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"
ESPNL	FLJ42568	ENSG00000144488	"Espin like"	Q6ZVH7	2	238100340-238133287	"Predicted intracellular proteins"	Hearing	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;intestine: 3.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 2.1;Granulosa cells: 1.7;Hepatocytes: 1.3;Muller glia cells: 1.6;Theca cells: 2.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 5.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 2.8"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055103	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 62: B-cells - B-cell activation"			"HPA055103: AB_2682694"	"unprognostic (8.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-6)"	"unprognostic (3.49e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.67e-2)"
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 42.2"	"Cell type enriched"	"Detected in some"	16	"B-cells: 143.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in many"	24	"memory B-cell: 200.9;naive B-cell: 496.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 496.2"	"Group enriched"	"Detected in some"	225	"Leukemia: 40.0;lymphoma: 36.4;Myeloma: 39.3"		"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"	NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206903317-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 65.5;lymphoid tissue: 180.6"	"Group enriched"	"Detected in many"	5	"B-cells: 338.5;NK-cells: 97.6;T-cells: 108.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"Leukemia: 20.3;lymphoma: 51.8;Myeloma: 40.0"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003910	Approved		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		5500000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane, Focal adhesion sites"		"HPA003910: AB_1078798"	"prognostic favorable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820120	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"bone marrow: 8.0;intestine: 8.6;lymphoid tissue: 27.3"	"Cell type enriched"	"Detected in some"	37	"B-cells: 100.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 39.3;naive B-cell: 68.1"	"Lineage enriched"	"Detected in many"	62	"B-cells: 68.1"	"Cancer enriched"	"Detected in single"	38	"lymphoma: 11.2"	"Heart muscle - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013323	Enhanced					NA	NA		290000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 20.9;lymphoid tissue: 34.3"	"Group enriched"	"Detected in some"	20	"B-cells: 74.6;Plasma cells: 45.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"memory B-cell: 29.7;naive B-cell: 18.4"	"Lineage enriched"	"Detected in single"	42	"B-cells: 29.7"	"Group enriched"	"Detected in some"	82	"lymphoma: 15.4;Myeloma: 5.6"	"Breast - Plasma cells, Lung - B-cells"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 46.2;Late spermatids: 10.8;NK-cells: 29.1;T-cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cancer enriched"	"Detected in single"	67	"lymphoma: 14.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Testis - Late spermatids"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573747-157598085	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 10.5"	"Cell type enriched"	"Detected in single"	4	"B-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"lymphoma: 1.6"						"Not detected"	"Not detected"			HPA054030	Approved					NA	NA				"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"
FCRLA	"FCRL, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595"	ENSG00000132185	"Fc receptor like A"	Q7L513	1	161706972-161714352	"Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 98.4"	"Group enriched"	"Detected in some"	4	"B-cells: 131.3;Melanocytes: 34.8"	"Cancer enriched"	"Detected in many"	21	"melanoma: 38.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"memory B-cell: 368.0;naive B-cell: 341.5"	"Lineage enriched"	"Detected in many"	10	"B-cells: 368.0"	"Group enriched"	"Detected in some"	4	"lymphoma: 179.0;skin cancer: 48.7"	"Skin - Melanocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016545	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB016545: AB_2247037"	"unprognostic (5.46e-4)"	"unprognostic (7.19e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.48e-4)"	"unprognostic (1.45e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.66e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.84e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-2)"
FP565260.3		ENSG00000277117	"ICOS ligand"		21	5022493-5040666	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 17.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.7;dendritic cells: 2.6;Gastric mucus-secreting cells: 1.8;Langerhans cells: 1.4;Microglial cells: 2.7;Oligodendrocytes: 1.8;Plasma cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"												HPA029179			Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane, Cytoplasmic bodies"		"HPA029179: AB_2732445"	"unprognostic (3.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.58e-4)"	"unprognostic (6.66e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-1)"
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Prostate basal glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067"	"unprognostic (1.27e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"
GH1	"GH, GH-N, GHN, hGH-N"	ENSG00000259384	"Growth hormone 1"	P01241	17	63917200-63918839	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	868	"pituitary gland: 59365.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA043715	Supported				"Secreted to blood"	NA	NA	2690000	6400000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA043715: AB_2678632"	"unprognostic (1.91e-2)"							"unprognostic (3.51e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.45e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.03e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.33e-1)"	
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702694	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	14	"brain: 360.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.9;dendritic cells: 129.9;Horizontal cells: 92.9;Muller glia cells: 87.2;Oligodendrocyte precursor cells: 98.2;Oligodendrocytes: 194.6;Plasma cells: 132.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9;melanoma: 20.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0"	"Group enriched"	"Detected in many"	4	"B-cells: 57.2;dendritic cells: 48.0"	"Group enriched"	"Detected in many"	6	"Leukemia: 14.7;lymphoma: 17.3;Myeloma: 27.2;skin cancer: 8.7"	"Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skin - Eccrine sweat gland cells, Testis - Sertoli cells"	"Region enriched"	"Detected in all"	6	"basal ganglia: 1277.2"					HPA057790	Supported	Supported				NA	NA		72000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA057790: AB_2683527"	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favorable (3.05e-4)"	"prognostic favorable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127535-19159187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;B-cells: 3.1;Endothelial cells: 2.1;Microglial cells: 10.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 9.1"	"Lineage enriched"	"Detected in many"	6	"B-cells: 9.1"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 32.7"										"HPA051796, HPA066654"	Uncertain		Approved	Centrosome		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Centrosome		"HPA051796: AB_2681613, HPA066654: AB_2685699"	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32820466	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 19.5;lymphoid tissue: 41.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 95.6;Langerhans cells: 26.5;Plasma cells: 28.0;Schwann cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 213.8;naive B-cell: 258.1"	"Lineage enriched"	"Detected in many"	20	"B-cells: 258.1"	"Cancer enriched"	"Detected in many"	7	"lymphoma: 18.1"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013846	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA013846: AB_1853928"	"prognostic favorable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"
HPS3	"BLOC2S1, SUTAL"	ENSG00000163755	"HPS3 biogenesis of lysosomal organelles complex 2 subunit 1"	Q969F9	3	149129638-149173732	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Sertoli cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046281, HPA052778"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 68: Kidney - Mixed function"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus, Plasma membrane"		"HPA046281: AB_10961641, HPA052778: AB_2681943"	"unprognostic (1.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.06e-2)"
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 162.1;lymphoid tissue: 72.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 182.2;dendritic cells: 70.3;Early spermatids: 85.7;Hofbauer cells: 63.7;Late spermatids: 72.5;Spermatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Leukemia: 31.5;lymphoma: 38.8;Myeloma: 32.1"	"Kidney - Fibroblasts, Prostate - Fibroblasts, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039329	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"
IGHE		ENSG00000211891	"Immunoglobulin heavy constant epsilon"	P01854	14	105597691-105601728	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lymphoid tissue: 4.6;thyroid gland: 2.6"	"Group enriched"	"Detected in some"	38	"B-cells: 98.0;Plasma cells: 48.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	60	"Myeloma: 140.0"	"Skin - Sebaceous gland cells"	"Not detected"	"Not detected"												"Immunoglobulin genes"	NA	NA		77000000		"Cluster 64: Macrophages - Immune response"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (3.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.99e-1)"		"unprognostic (4.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-1)"
IGHV7-81		ENSG00000211979	"Immunoglobulin heavy variable 7-81 (non-functional)"	A0A0B4J1V7	14	106874583-106875071	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.7;lymphoid tissue: 18.3;stomach 1: 12.3"	"Group enriched"	"Detected in some"	4	"B-cells: 2.9;Plasma cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 5.5;naive B-cell: 3.9"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.5"	"Cancer enhanced"	"Detected in some"		"lymphoma: 9.4;Rhabdoid: 3.7"	"Breast - Plasma cells, Lung - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"														"Immunoglobulin genes"	NA	NA		270000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (5.71e-4)"	"unprognostic (3.87e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.85e-2)"		"unprognostic (2.67e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-1)"		"unprognostic (1.14e-2)"	"unprognostic (6.16e-5)"	"unprognostic (1.69e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.63e-2)"
IGLJ3		ENSG00000211678	"Immunoglobulin lambda joining 3"		22	22904850-22905025	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8"	"Group enriched"	"Detected in some"	32	"B-cells: 3.7;Plasma cells: 2.8"	"Group enriched"	"Detected in some"	13	"colorectal cancer: 5.1;endometrial cancer: 10.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Group enriched"	"Detected in many"	24	"memory B-cell: 1223.9;naive B-cell: 1139.6"	"Lineage enriched"	"Detected in many"	25	"B-cells: 1223.9"	"Cancer enriched"	"Detected in some"	9	"Myeloma: 639.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"						"unprognostic (1.19e-1)"	"unprognostic (2.06e-3)"				"unprognostic (2.05e-1)"						"unprognostic (1.37e-1)"	"unprognostic (5.00e-1)"		
IGLV3-12		ENSG00000211667	"Immunoglobulin lambda variable 3-12"	A0A075B6K2	22	22771824-22772582	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.1"	"Group enriched"	"Detected in some"	11	"B-cells: 1.2;Plasma cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.2;memory B-cell: 9.2;memory CD8 T-cell: 4.0;naive B-cell: 6.7;NK-cell: 5.6"	"Group enriched"	"Detected in many"	64	"B-cells: 9.2;NK-cells: 5.6;T-cells: 4.2"	"Not detected"	"Not detected"			"Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"														"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (1.92e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.03e-2)"		"prognostic favorable (8.39e-6)"		"unprognostic (8.44e-2)"		"unprognostic (4.62e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.15e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"
IGLV8-61		ENSG00000211638	"Immunoglobulin lambda variable 8-61"	A0A075B6I0	22	22098700-22099212	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 805.8;lymphoid tissue: 984.2"	"Group enriched"	"Detected in some"	6	"B-cells: 9.4;Plasma cells: 14.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Group enriched"	"Detected in some"	630	"memory B-cell: 257.8;naive B-cell: 529.3"	"Lineage enriched"	"Detected in single"	848	"B-cells: 529.3"	"Cancer enriched"	"Detected in some"	9	"lymphoma: 15.6"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"					"Low region specificity"	"Detected in all"								"Immunoglobulin genes"	NA	NA		620000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (1.07e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-1)"
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	6	"B-cells: 132.3;granulocytes: 38.5;NK-cells: 136.0;Plasma cells: 78.4;Serous glandular cells: 48.9;T-cells: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Group enriched"	"Detected in many"	8	"lymphoma: 46.8;Myeloma: 34.0"	"Adipose subcutaneous - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 72.7;granulocytes: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 135.3"	"Kidney - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 111.4;dendritic cells: 74.2;Kupffer cells: 66.3;Microglial cells: 177.0;monocytes: 80.0;NK-cells: 145.8;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 42.4;lymphoma: 37.0;Myeloma: 12.3;testis cancer: 11.1"	"Adipose subcutaneous - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153598	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.1;dendritic cells: 1.7;granulocytes: 4.7"	"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Breast - Breast glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071568			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA071568: "	"prognostic favorable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.74e-4)"	"prognostic favorable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.3"	"Cell type enriched"	"Detected in single"	9	"B-cells: 6.5"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"memory B-cell: 6.5;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	18	"B-cells: 6.5"	"Cancer enhanced"	"Detected in single"		"Leukemia: 2.0"	"Testis - Endothelial cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055919	Approved				"Secreted in male reproductive system"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 62: B-cells - B-cell activation"			"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	99	"epididymis: 83.7"	"Group enriched"	"Detected in some"	9	"B-cells: 13.9;Plasma cells: 4.5"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	60	"memory B-cell: 4.1;naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	79	"B-cells: 8.1"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.0"		"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"							"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"	
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Skin - Keratinocyte (other), Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 62: B-cells - B-cell activation"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 15: Non-specific - Protein binding"	"Cluster 62: B-cells - B-cell activation"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"
LRIF1	"C1orf103, FLJ11269, RIF1"	ENSG00000121931	"Ligand dependent nuclear receptor interacting factor 1"	Q5T3J3	1	110947190-110963965	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044515	Uncertain		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	"Centriolar satellite"	"HPA044515: AB_10796800"	"unprognostic (5.06e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.74e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.14e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.70e-1)"
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 245.9;dendritic cells: 62.8;Langerhans cells: 37.8;Plasma cells: 72.1;T-cells: 45.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 12.3;Myeloma: 38.9"	"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Pancreas - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"
MAGED4B		ENSG00000187243	"MAGE family member D4B"	Q96JG8	X	52061827-52069248	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;pituitary gland: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	22	"B-cells: 5.1;dendritic cells: 3.8;T-cells: 3.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 43.0"										HPA003554	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 6: BEWO - Unknown function"	"Cluster 62: B-cells - B-cell activation"			"HPA003554: AB_1853497"					"unprognostic (7.75e-2)"			"unprognostic (2.19e-1)"		"unprognostic (2.37e-2)"				"unprognostic (7.01e-6)"	"unprognostic (6.45e-2)"		
MAPK8IP3	"JIP3, JSAP1, KIAA1066, syd"	ENSG00000138834	"Mitogen-activated protein kinase 8 interacting protein 3"	Q9UPT6	16	1706183-1770351	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 61.2;Horizontal cells: 73.7;Inhibitory neurons: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005580, HPA041785, HPA069311"	Approved		Approved	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: TE 441.T - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Vesicles		"CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116"	"unprognostic (1.49e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.28e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.83e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.91e-3)"	"prognostic unfavorable (5.25e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (3.95e-4)"
MATN1	"CMP, CRTM"	ENSG00000162510	"Matrilin 1"	P21941	1	30711277-30723585	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.3;retina: 5.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.0;Breast myoepithelial cells: 1.2;granulocytes: 1.6"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 1.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028580	Supported				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 62: B-cells - B-cell activation"			"HPA028580: AB_10601913"	"unprognostic (4.71e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.75e-6)"	"unprognostic (9.93e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.31e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.01e-13)"	"unprognostic (8.23e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-2)"	"unprognostic (3.42e-2)"
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430947-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: Non-specific - Mitochondria"	"Cluster 62: B-cells - B-cell activation"	"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"
METTL8	"FLJ13984, TIP"	ENSG00000123600	"Methyltransferase like 8"		2	171317405-171434802	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035421	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA035421: AB_10670116"	"unprognostic (3.13e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.94e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.83e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.59e-3)"
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Prostate glandular cells, Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 63: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	55	"B-cells: 982.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 350.5"	"Breast - T-cells, Lung - B-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789376	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 86.4;lymphoid tissue: 97.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.1;dendritic cells: 17.8;Macrophages: 28.0;Plasma cells: 85.1;T-cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1165.0;classical monocyte: 673.5;eosinophil: 1467.3;neutrophil: 2128.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 2128.0;monocytes: 673.5"	"Cancer enhanced"	"Detected in some"		"Leukemia: 30.5;lymphoma: 81.5"	"Kidney - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501887-47656877	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 157.3;Plasma cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"
NIBAN3	"BCNP1, FAM129C, FLJ39802"	ENSG00000167483	"Niban apoptosis regulator 3"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"bone marrow: 15.4;intestine: 16.6;lymphoid tissue: 34.7"	"Group enriched"	"Detected in some"	37	"B-cells: 140.9;dendritic cells: 228.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	379	"memory B-cell: 31.9;naive B-cell: 52.1;plasmacytoid DC: 110.7"	"Group enriched"	"Detected in many"	476	"B-cells: 52.1;dendritic cells: 110.7"	"Group enriched"	"Detected in some"	61	"Leukemia: 40.6;lymphoma: 90.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - B-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA043277	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Cytosol"		"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"
NIPA2	SLC57A2	ENSG00000140157	"NIPA magnesium transporter 2"	Q8N8Q9	15	22838644-22869362	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"
NKX6-3	FLJ25169	ENSG00000165066	"NK6 homeobox 3"	A6NJ46	8	41645177-41650817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 10.8;stomach 1: 28.0"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 2.4;Horizontal cells: 1.3"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.1;stomach cancer: 3.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 5.6"	"Pancreas - Beta cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (1.87e-1)"	"unprognostic (9.91e-3)"		"unprognostic (4.04e-1)"	"unprognostic (5.73e-2)"			"unprognostic (1.98e-1)"		"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-1)"	
NPBWR2	GPR8	ENSG00000125522	"Neuropeptides B and W receptor 2"	P48146	20	64105820-64107171	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Not detected"	"Not detected"									NA	NA					"Cluster 46: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"													"unprognostic (1.44e-1)"							
OR2G6		ENSG00000188558	"Olfactory receptor family 2 subfamily G member 6"	Q5TZ20	1	248508073-248527337	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		NA	NA					"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"																				
OR56B1	OR56B1P	ENSG00000181023	"Olfactory receptor family 56 subfamily B member 1"	Q8NGI3	11	5736448-5738523	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045043	Uncertain					NA	NA						"Cluster 62: B-cells - B-cell activation"			"HPA045043: AB_10794296"																	
OR56B2P	OR56B2	ENSG00000181017	"Olfactory receptor family 56 subfamily B member 2 pseudogene"		11	5761153-5767465	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 62: B-cells - B-cell activation"																				
ORAI2	"C7orf19, CBCIP2, FLJ12474, FLJ14733, H_NH0514P08.8, TMEM142B"	ENSG00000160991	"ORAI calcium release-activated calcium modulator 2"	Q96SN7	7	102433106-102456825	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 116.3;Endometrial ciliated cells: 75.8;Glandular and luminal cells: 69.2;Plasma cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 75.9"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055137, HPA065937"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA055137: AB_2682712, HPA065937: AB_2685581"	"unprognostic (5.09e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.07e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (8.49e-5)"	"unprognostic (7.16e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (2.46e-1)"
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 115.4;Plasma cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cancer enhanced"	"Detected in many"		"lymphoma: 60.7;Myeloma: 38.7"	"Breast - Plasma cells, Lung - B-cells, Thyroid - Plasma cells"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"
PARP15	"ARTD7, FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577628-122639047	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 86.0;granulocytes: 13.0;NK-cells: 41.7;T-cells: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Leukemia: 18.2;lymphoma: 18.0"	"Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"					"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833269-37034268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 39.7"	"Cell type enriched"	"Detected in some"	9	"B-cells: 112.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"midbrain: 6.5"	"Group enriched"	"Detected in some"	43	"memory B-cell: 39.0;naive B-cell: 26.0"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.0"	"Group enriched"	"Detected in some"	11	"Leukemia: 32.8;lymphoma: 76.6"	"Lung - B-cells, Skin - Outer root sheath cells"	"Region enriched"	"Detected in single"	11	"midbrain: 3.9"	"Low region specificity"	"Detected in all"			"CAB026269, CAB026869, HPA056394"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"CAB026269: , CAB026869: , HPA056394: AB_2683116"	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266255-208358746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Lipid metabolism"	"Kinase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042604	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 84.2;Microglial cells: 93.0;NK-cells: 44.5;Plasma cells: 97.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 34.8;lymphoma: 123.9;Myeloma: 32.1"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Kidney - Intercalated cells, Liver - Hepatocytes, Prostate - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"
PLEKHF2	"FLJ13187, PHAFIN2, ZFYVE18"	ENSG00000175895	"Pleckstrin homology and FYVE domain containing 2"	Q9H8W4	8	95133785-95156685	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 84.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024829	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA024829: AB_10603127"	"unprognostic (4.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (9.67e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (5.94e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.61e-3)"
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Group enriched"	"Detected in many"	5	"Adipocytes: 86.7;Astrocytes: 95.5;B-cells: 58.6;Endothelial cells: 58.1;Microglial cells: 127.7;Oligodendrocytes: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Sertoli cells"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 254.1;Kupffer cells: 109.0;Langerhans cells: 139.6;Macrophages: 109.5;monocytes: 315.9;Plasma cells: 115.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 94.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"lymphoma: 97.6;Myeloma: 30.3"	"Adipose subcutaneous - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"
PRDM2	"HUMHOXY1, KMT8, KMT8A, MTB-ZF, RIZ, RIZ1, RIZ2"	ENSG00000116731	"PR/SET domain 2"	Q13029	1	13700198-13825079	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005809	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Golgi apparatus"		"HPA005809: AB_1079673"	"unprognostic (2.22e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.81e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.85e-3)"
PRDM4	PFM1	ENSG00000110851	"PR/SET domain 4"	Q9UKN5	12	107732871-107761272	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024322, HPA067437"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA024322: AB_1855691, HPA067437: AB_2685839"	"unprognostic (4.64e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (9.64e-2)"	"unprognostic (9.06e-3)"	"unprognostic (5.31e-2)"	"prognostic favorable (3.15e-7)"	"unprognostic (9.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.62e-3)"
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685799-107713162	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli rim,Golgi apparatus"		Yes	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	"Nucleoli rim"	"Golgi apparatus"	"HPA038708: AB_2676163"	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (9.65e-4)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA amidotransferase subunit QRSL1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"memory B-cell: 86.4;naive B-cell: 71.0"	"Lineage enriched"	"Detected in all"	7	"B-cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245812	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		9600000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 55: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.2;testis: 77.0"	"Cell type enhanced"	"Detected in all"		"B-cells: 273.2;Late spermatids: 186.4;Rod photoreceptor cells: 415.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 26.7;naive B-cell: 21.0"	"Lineage enriched"	"Detected in many"	11	"B-cells: 26.7"	"Low cancer specificity"	"Detected in all"			"Colon - Enteric glia cells, Liver - Hepatocytes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167708696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 115.5;skeletal muscle: 147.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 273.0;Cardiomyocytes: 82.8;Kupffer cells: 111.0;Macrophages: 95.6;monocytes: 117.1;NK-cells: 113.7;T-cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"Leukemia: 129.7;lymphoma: 136.2;Myeloma: 89.5"	"Colon - T-cells, Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		200000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.8;Microglial cells: 55.6;Oligodendrocyte precursor cells: 53.4;Oligodendrocytes: 102.9;Plasma cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 62: B-cells - B-cell activation"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"
RIC1	"bA207C16.1, KIAA1432"	ENSG00000107036	"RIC1 homolog, RAB6A GEF complex partner 1"	Q4ADV7	9	5629025-5776557	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.4;Inhibitory neurons: 77.8;Microglial cells: 95.8;Oligodendrocyte precursor cells: 66.9;Oligodendrocytes: 66.6;Plasma cells: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051578	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 62: B-cells - B-cell activation"			"HPA051578: AB_2681541"	"unprognostic (1.78e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.16e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202179-56221933	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 107.0;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 92.4;Oligodendrocytes: 89.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 15: Non-specific - Protein binding"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"
RP9	PAP-1	ENSG00000164610	"RP9 pre-mRNA splicing factor"	Q8TA86	7	33094797-33109404	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 63: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4 Y-linked 2"	Q8TD47	Y	20756108-20781032	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 1.9;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.9;Spermatocytes: 1.5;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 7.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Not detected"	"Not detected"			"Prostate - Prostate glandular cells"									HPA000857	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"		
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 132.8;dendritic cells: 91.9;Late spermatids: 126.6;Microglial cells: 62.0;Schwann cells: 56.3"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Cancer enriched"	"Detected in many"	5	"lymphoma: 143.4"	"Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 58: Non-specific - Basic cellular processes"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"
SH2B2	APS	ENSG00000160999	"SH2B adaptor protein 2"		7	102285091-102321711	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 37.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.7;Extravillous trophoblasts: 76.3;Plasma cells: 34.8;Skeletal myocytes: 31.7;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.4;granulocytes: 1.8;monocytes: 1.6"	"Group enriched"	"Detected in all"	5	"lymphoma: 44.2;Myeloma: 55.7"	"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051131	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA051131: AB_2681354"	"unprognostic (2.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.32e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.99e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (3.42e-2)"
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633168-52669683	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;NK-cells: 20.2;Plasma cells: 9.2;T-cells: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.7"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0"	"Group enriched"	"Detected in some"	9	"Leukemia: 1.3;lymphoma: 3.3;Myeloma: 4.2"	"Adipose visceral - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.0"	"Low region specificity"	"Detected in some"			HPA030744	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638101-65650918	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.6"	"Cell type enhanced"	"Detected in many"		"NK-cells: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Vascular Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 33.6;Basal squamous epithelial cells: 25.3;Excitatory neurons: 29.8;Inhibitory neurons: 25.2;Microglial cells: 23.7;Oligodendrocyte precursor cells: 24.5;Oligodendrocytes: 44.0;Plasma cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"									"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 62: B-cells - B-cell activation"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838009	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Hypotrichosis, Intellectual disability, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Myeloma: 21.4"	"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753738-43758791	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 13.3"	"Group enriched"	"Detected in some"	8	"B-cells: 1.6;Cholangiocytes: 1.9;Collecting duct cells: 5.9;Pancreatic endocrine cells: 1.7"	"Cancer enhanced"	"Detected in some"		"lung cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 11.9;Rhabdoid: 19.1"		"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.0"	"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA		16000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 61: Liver - Metabolism"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (1.26e-1)"	"unprognostic (4.06e-2)"		"unprognostic (6.57e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.37e-1)"		"unprognostic (4.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.38e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.56e-1)"		"unprognostic (7.90e-2)"
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in all"		"B-cells: 215.0;dendritic cells: 153.7;monocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Colon - Endothelial cells, Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells, Thyroid - T-cells"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.6;lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 148.0;monocytes: 37.4;NK-cells: 61.8;Plasma cells: 81.0;T-cells: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 97.5"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"lymphoma: 41.9;Myeloma: 17.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Testis - Early spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"							"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"
SP140L		ENSG00000185404	"SP140 nuclear body protein like"	Q9H930	2	230327184-230403732	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 57.9;NK-cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Thyroid - T-cells"									HPA055864	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA055864: AB_2682949"	"unprognostic (1.44e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.70e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (5.09e-10)"	"unprognostic (9.15e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-3)"
STAG3		ENSG00000066923	"Stromal antigen 3"	Q9UJ98	7	100177563-100221488	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Chromosome partition, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	66	"testis: 54.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 73.4;Hepatocytes: 27.4;Spermatocytes: 133.2;Spermatogonia: 31.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bile duct cancer: 7.6"	"Testis - Spermatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA049106, HPA058330"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 39: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	Nucleoli	Nucleoplasm	"HPA049106: AB_2680634, HPA058330: AB_2683681"	"unprognostic (6.56e-4)"	"prognostic favorable (8.45e-4)"	"unprognostic (1.25e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.31e-4)"	"unprognostic (4.26e-4)"	"unprognostic (7.48e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.07e-4)"
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 68.2;dendritic cells: 22.6;Distal tubular cells: 28.0;granulocytes: 55.6;Plasma cells: 134.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"Leukemia: 14.5;lymphoma: 55.0"	"Colon - Mast cells, Kidney - Intercalated cells, Testis - Early spermatids"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			"HPA038529, HPA058018"	Enhanced		Supported	"Nucleoplasm,Centriolar satellite,Mitochondria,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Centriolar satellite, Mitochondria"	Cytosol	"HPA038529: AB_10673011, HPA058018: "	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		380000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 62: B-cells - B-cell activation"	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 148.2;B-cells: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Colon - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Thyroid - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 136.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"
TAF1A	"SL1, TAFI48"	ENSG00000143498	"TATA-box binding protein associated factor, RNA polymerase I subunit A"	Q15573	1	222557902-222589933	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054334	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA054334: AB_2682453"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.26e-6)"	"unprognostic (7.98e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.98e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.06e-2)"
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 235.3;dendritic cells: 89.0;Langerhans cells: 70.5;Macrophages: 85.3;monocytes: 75.4;NK-cells: 128.5;Plasma cells: 202.8;T-cells: 211.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 9.8;lymphoma: 16.6;Myeloma: 7.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Fibroblasts, Testis - Peritubular cells, Thyroid - T-cells"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"
TAL2	bHLHa19	ENSG00000186051	"TAL bHLH transcription factor 2"	Q16559	9	105662457-105663124	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 2.7;Cone photoreceptor cells: 8.6;Distal tubular cells: 12.4;Muller glia cells: 3.1;Proximal tubular cells: 3.2;Skeletal myocytes: 4.9"	"Group enriched"	"Detected in some"	4	"renal cancer: 1.6;testis cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 6.9;naive B-cell: 7.3"	"Lineage enriched"	"Detected in many"	4	"B-cells: 7.3"	"Cancer enriched"	"Detected in some"	27	"Rhabdoid: 35.4"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030886	Uncertain		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA030886: AB_10601596"	"unprognostic (3.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.00e-4)"	"unprognostic (2.84e-2)"	"prognostic favorable (2.69e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.39e-2)"
TAS2R9	"T2R9, TRB6"	ENSG00000121381	"Taste 2 receptor member 9"	Q9NYW1	12	10809094-10810168	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Not detected"	"Not detected"									NA	NA						"Cluster 62: B-cells - B-cell activation"																				
TBC1D22A	C22orf4	ENSG00000054611	"TBC1 domain family member 22A"	Q8WUA7	22	46762617-47175699	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 246.3;Oligodendrocytes: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001173, HPA078026"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA001173: AB_1080212, HPA078026: "	"unprognostic (1.62e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-2)"	"unprognostic (8.17e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.39e-1)"
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"
TCL1A	TCL1	ENSG00000100721	"TCL1 family AKT coactivator A"	P56279	14	95709947-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 267.6"	"Group enriched"	"Detected in some"	6	"B-cells: 291.2;dendritic cells: 387.7"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	296	"memory B-cell: 874.7;naive B-cell: 2160.3;plasmacytoid DC: 1099.9"	"Group enriched"	"Detected in all"	350	"B-cells: 2160.3;dendritic cells: 1099.9"	"Group enriched"	"Detected in some"	223	"Leukemia: 216.1;lymphoma: 458.2"	"Testis - Spermatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 91.9;Syncytiotrophoblasts: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 16.1;eosinophil: 16.9;intermediate monocyte: 16.3;memory B-cell: 34.2;myeloid DC: 14.7;naive B-cell: 22.6;neutrophil: 47.4;non-classical monocyte: 14.1"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"lymphoma: 41.4"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067082			Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	Cytosol		"HPA067082: "	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"
TGIF2-RAB5IF	TGIF2-C20orf24	ENSG00000259399	"TGIF2-RAB5IF readthrough"		20	36574553-36612384	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076106			Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	Mitochondria		"HPA076106: "	"unprognostic (7.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.57e-3)"	"unprognostic (3.97e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 59.4;dendritic cells: 13.2;Microglial cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 27.2"	"Adipose visceral - Neutrophils, Prostate - T-cells"					"Low region specificity"	"Detected in many"			HPA001940			Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	"Endoplasmic reticulum"	"HPA001940: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"
TLR9	CD289	ENSG00000239732	"Toll like receptor 9"	Q9NR96	3	52221080-52225645	"CD markers, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.1;lymphoid tissue: 6.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.4;Plasma cells: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"plasmacytoid DC: 166.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 166.9"	"Group enriched"	"Detected in some"	29	"Leukemia: 3.5;lymphoma: 12.1;Myeloma: 5.1"																NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (6.03e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.69e-7)"	"unprognostic (1.16e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.91e-3)"
TMED8	FAM15B	ENSG00000100580	"Transmembrane p24 trafficking protein family member 8"	Q6PL24	14	77335029-77377094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001205	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	"Plasma membrane"	Vesicles	"HPA001205: AB_2204460"	"unprognostic (1.07e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.77e-1)"
TMEM131L	"DKFZp586H1322, KIAA0922"	ENSG00000121210	"Transmembrane 131 like"	A2VDJ0	4	153466346-153636711	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.4;lymphoid tissue: 48.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 60.7;Inhibitory neurons: 60.4;Late spermatids: 60.4;Oligodendrocyte precursor cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Leukemia: 33.6;lymphoma: 52.6"	"Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043472, HPA048443"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Vesicles	"Nucleoli fibrillar center"	"HPA043472: AB_2678496, HPA048443: AB_2680395"	"unprognostic (1.12e-1)"	"prognostic favorable (6.69e-6)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-2)"
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 26.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 82.4;Microglial cells: 66.6;NK-cells: 28.6;Plasma cells: 92.1;Schwann cells: 23.4;T-cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 74.8"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Heart muscle - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 46: Non-specific - Unknown function"	"Cluster 62: B-cells - B-cell activation"				"prognostic favorable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"
TMEM19	FLJ10936	ENSG00000139291	"Transmembrane protein 19"	Q96HH6	12	71686082-71705047	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 75.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016830	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"			"HPA016830: AB_1858107"	"unprognostic (8.22e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.45e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.42e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.00e-1)"
TMEM243	"C7orf23, MGC4175, MM-TRAG"	ENSG00000135185	"Transmembrane protein 243"	Q9BU79	7	87196160-87220587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 182.6;Early spermatids: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014918	Uncertain					NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA014918: AB_2067447"	"unprognostic (5.14e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.32e-2)"	"prognostic favorable (9.13e-4)"
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.9;lymphoid tissue: 33.0;skeletal muscle: 62.9"	"Group enriched"	"Detected in some"	26	"B-cells: 122.9;Plasma cells: 135.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	41	"memory B-cell: 130.9;naive B-cell: 51.8"	"Lineage enriched"	"Detected in many"	59	"B-cells: 130.9"	"Group enriched"	"Detected in some"	8	"lymphoma: 59.0;Myeloma: 140.6"	"Adipose subcutaneous - Plasma cells, Breast - Plasma cells, Stomach - Plasma cells, Thyroid - Plasma cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922032-41926806	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 33.8;lymphoid tissue: 58.1"	"Cell type enriched"	"Detected in some"	16	"B-cells: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"memory B-cell: 22.5;naive B-cell: 29.1"	"Lineage enriched"	"Detected in single"	40	"B-cells: 29.1"	"Group enriched"	"Detected in many"	5	"Leukemia: 9.5;lymphoma: 22.9"	"Heart muscle - Cardiomyocytes, Lung - B-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003246, CAB008380"	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favorable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"
TRAF5	RNF84	ENSG00000082512	"TNF receptor associated factor 5"	O00463	1	211326615-211374946	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 79.5;Early spermatids: 52.4;granulocytes: 56.4;Late spermatids: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Peritubular cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008052, CAB010277"	Enhanced		Supported	Centrosome,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 62: B-cells - B-cell activation"	Cytosol	Centrosome	"CAB010277: AB_2287961, HPA008052: AB_1858230"	"unprognostic (6.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (2.94e-10)"	"unprognostic (3.72e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-2)"	"prognostic favorable (7.29e-5)"
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689697-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 140.2;dendritic cells: 148.9;monocytes: 118.7;NK-cells: 102.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 67.3;lymphoid tissue: 76.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"												HPA011403	Approved					NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"		"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 62: B-cells - B-cell activation"			"HPA011403: AB_2668503"																	
USP6NL	"KIAA0019, RN-tre, RNTRE, TRE2NL, USP6NL-IT1"	ENSG00000148429	"USP6 N-terminal like"	Q92738	10	11453946-11611754	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 141.4;Oligodendrocyte precursor cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 4.0;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 4.0"	"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039196	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA039196: AB_10795031"	"unprognostic (1.64e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.54e-2)"
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 2.2;Early spermatids: 7.0;granulocytes: 1.6;Late spermatids: 2.6;Oligodendrocyte precursor cells: 2.9;Plasma cells: 1.9;Spermatocytes: 1.8;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.8;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.8"	"Group enriched"	"Detected in many"	4	"lymphoma: 13.3;Rhabdoid: 3.3"	"Testis - Early spermatids"	"Region enriched"	"Detected in some"	9	"pons and medulla: 11.3"	"Region enriched"	"Detected in single"	46	"spinal cord: 6.0"	HPA026992	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"
UVRAG	VPS38	ENSG00000198382	"UV radiation resistance associated"	Q9P2Y5	11	75815210-76144232	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 142.5;Microglial cells: 174.2;Oligodendrocytes: 341.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016932	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA016932: AB_1858707"	"unprognostic (3.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.03e-1)"
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 51.5;intestine: 72.5;lymphoid tissue: 118.5"	"Cell type enriched"	"Detected in some"	17	"B-cells: 283.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	709	"memory B-cell: 753.3;naive B-cell: 803.7"	"Lineage enriched"	"Detected in many"	732	"B-cells: 803.7"	"Group enriched"	"Detected in some"	27	"Leukemia: 133.2;lymphoma: 280.9"		"Low region specificity"	"Detected in single"							HPA003041	Supported				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"
YPEL3	MGC10500	ENSG00000090238	"Yippee like 3"	P61236	16	30092314-30096915	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 23.2;eosinophil: 31.0;neutrophil: 47.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 47.4"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030501, HPA045621"	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 62: B-cells - B-cell activation"			"HPA030501: AB_10602683, HPA045621: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.64e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120574-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 222.3;Inhibitory neurons: 224.4;Oligodendrocyte precursor cells: 187.7;Oligodendrocytes: 236.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"
ZNF107	"smap-7, ZFD25, ZNF588"	ENSG00000196247	"Zinc finger protein 107"	Q9UII5	7	64666083-64711582	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells"															NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.15e-3)"
ZNF296	ZNF342	ENSG00000170684	"Zinc finger protein 296"	Q8WUU4	19	45071500-45076587	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 49.7;Basal squamous epithelial cells: 84.9;Plasma cells: 41.8;Squamous epithelial cells: 105.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 18.0"		"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA046940, HPA049576"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Centrosome	"HPA046940: AB_2679871, HPA049576: AB_2680821"	"unprognostic (1.32e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.67e-5)"	"unprognostic (7.14e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-3)"
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619161	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Thyroid - Thyroid glandular cells"									"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Non-specific - Transcription"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Nucleoli	"HPA049770: AB_2680871, HPA073463: AB_2686606"	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"
ZNF669	FLJ12606	ENSG00000188295	"Zinc finger protein 669"	Q96BR6	1	247099962-247104372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"									HPA044043	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: Non-specific - RNA binding"	"Cluster 62: B-cells - B-cell activation"			"HPA044043: AB_10964039"	"unprognostic (1.88e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.59e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.81e-2)"
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64356634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 66.1;Rod photoreceptor cells: 57.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"												"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 4: Non-specific - Transcription"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favorable (8.65e-4)"
ZNF821		ENSG00000102984	"Zinc finger protein 821"	O75541	16	71859680-71895336	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 21.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.4;Late spermatids: 66.4;Spermatocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 9.5;naive B-cell: 13.4;T-reg: 5.6"	"Group enriched"	"Detected in many"	9	"B-cells: 13.4;T-cells: 5.6"	"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036372, HPA042742"	Enhanced		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: Neuroblastoma - Neuronal signaling"	"Cluster 62: B-cells - B-cell activation"	"Nucleoplasm, Nuclear speckles"		"HPA036372: AB_10669790, HPA042742: AB_2678140"	"unprognostic (3.16e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.12e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.04e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (2.83e-2)"	"prognostic favorable (6.32e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-1)"
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981750-31991723	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 19.9;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 7.0;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	56	"B-cells: 7.0"	"Low cancer specificity"	"Detected in many"			"Testis - Sertoli cells"									HPA063386	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 6: BEWO - Unknown function"	"Cluster 62: B-cells - B-cell activation"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"
ZNF92	"HPF12, TF12"	ENSG00000146757	"Zinc finger protein 92"	Q03936	7	65373799-65401136	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Testis - Spermatocytes"									HPA003173			Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Non-specific - Transcription"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm		"HPA003173: AB_1080744"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (5.48e-3)"	"unprognostic (1.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.50e-3)"